Company: SRPT
Filing Date: 2025-02-28
Form Type: 10-K
Source: 0000950170-25-029973
Chunk: 119

Company: Sarepta Therapeutics, Inc.
Filing Date: 2025-02-28
Form: 10-K
Item: Item 15
Chunk 119
---
 10.3
     
    10/31/18

     10.37†
     
    Form of Stock Appreciation Right Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.4
     
    10/31/18

     10.38†
     
    Form of Performance-Based Restricted Stock Unit Award Agreement under Sarepta Therapeutics, Inc. 2018 Equity Incentive Plan
     
    10-Q
     
    001-14895
     
    10.1
     
    05/4/22

     10.39†
     
    Amendment to Restricted Stock Award Agreement between Douglas S. Ingram and Sarepta Therapeutics, Inc. dated December 17, 2018
     
    10-K
     
    001-14895
     
    10.75
     
    2/28/19

     10.40^
     
    Amendment No. 1 to License Agreement between Sarepta Therapeutics, Inc. and ST International Holdings Two, Inc. on the one hand and BioMarin Leiden Holding BV, BioMarin Nederlands BV and BioMarin Technologies BV on the other hand
     
    10-Q
     
    001-14895
     
    10.1
     
    8/7/19

     10.41†
     
    Amendment No. 1 to the Sarepta Therapeutics, Inc. Amended and Restated 2013 Employment Stock Purchase Plan (as Amended and Restated on June 27, 2016)
     
    10-Q
     
    001-14895
     
    10.4
     
    8/7/19

     10.42
     
    Letter Agreement between Sarepta Therapeutics, Inc. and Myonexus Therapeutics, Inc. dated February 26, 2019
     
    10-Q
     
    001-14895
     
    10.1
     
    5/8/19

     10.43†
     
    Form of Executive Vice President Severance Letter Agreement